Antiproliferative effect of Toona sinensis leaf extract on non-small-cell lung cancer

Translational Research

Volumn 155, Issue 6, 2010, Pages 305-314

  Yang, Chih Jen ^a   Huang, Yu Jung ^a   Wang, Cheng Yuan ^a   Wang, Pei Hui ^a   Hsu, Hseng Kuang ^a   Tsai, May Jywan ^b   Chen, Yu Chu ^c   Bharath Kumar, V ^d   Huang, Ming Shyan ^a   Weng, Ching Feng ^d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

^d NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; GEMCITABINE; LIPOCORTIN 5; NAVELBINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P27; TAXANE DERIVATIVE; TOONA SINENSIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CEDRELA; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG MEGADOSE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MOLECULAR MECHANICS; MOUSE; NICK END LABELING; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; TOONA SINENSIS; TUMOR REGRESSION; TUMOR XENOGRAFT; UPREGULATION;

EID: 77952109581     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.03.002     Document Type: Article

References (33)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 56 106 (2006) 130
2. AbouEl Hassan M.A., Braam S.R., and Kruyt F.A. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells. Cancer Gene Ther 13 (2006) 1105-1114
3. Losiewicz M.D., Carlson B.A., Kaur G., Sausville E.A., and Worland P.J. Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275. Biochem Biophys Biophys Res Commun 201 (1994) 589-595
4. Carlson B.A., Dubay M.M., Sausville E.A., Brizuela L., and Worland P.J. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase CDC2 and CDK4 in human breast carcinoma cells. Cancer Res 56 (1996) 2973-2978
5. Carlson B.A., Pearlstein R.A., Naik R.G., Sedlacek H.H., Sausville E.A., and Worland P.J. Inhibition of CDK2, CDK4 and CDK7 by flavopiridol and structural analogs. Proc Am Assoc Cancer Res 34 (1996) 424
6. Dumant JA. HMR Report No. B/98/0189/R, B/98/0188/R, 8/98/0187/R. HMR Oncology; 1996.
7. Seynaeve C.M., Stetler-Stevenson M., Sebers S., Kaur G., Sausville E.A., and Worland P.J. Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 inhuman breast carcinoma cells. Cancer Res 53 (1993) 2081-2086
8. Akinaga S., Nomura K., Gomi K., and Okabe M. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoind carcinoma, A431 cells. Cancer Chemother Pharmacol 33 (1994) 273-280
9. Kawakami K., Futami H., Takahara J., and Yamaguchi K. UCN-01, 7 hydroxylstaurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem Biophys Res Commun 219 (1996) 778-783
10. Wille J.J., and Scott R.E. Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the G1-phase of the cell cycle. J Cell Physiol 112 (1982) 115-122
11. Carney D.N. Lung cancer-time to move on from chemotherapy. New Engl J Med 2 (2002) 126-128
12. Chang H.C., Hung W.C., Huang M.S., and Hsu H.K. Extract from the leaves of Toona sinensis roemor exerts potent antiproliferative effect on human lung cancer cells. Am J Chin Med 30 (2002) 307-314
13. Chang H.L., Hsu H.K., Su J.H., et al. The fractionated Toona sinensis leaf extract induces apoptosis of human ovarian cancer cells and inhibits tumor growth in a murine xenograft model. Gynecol Oncol 102 (2006) 309-314
14. Yang H.L., Chang W.H., Chia Y.C., et al. Toona sinensis extracts induces apoptosis via reactive oxygen species in human premyelocytic leukemia cells. Food Chem Toxicol 44 (2006) 1978-1988
15. Yang C.J., Huang Y.J., Wang C.Y., et al. Anti-proliferative and anti-tumorgenic activity of Toona sinensis leaf extracts in lung adenocarcinoma. J Med Food 155 (2010) 305-314
16. Wang P.H., Tsai M.J., Hsu C.Y., Wang C.Y., Hsu H.K., and Weng C.F. Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4. Food Chem Toxicol 46 (2008) 2554-2560
17. Yang C.J., Wang C.S., Hung J.Y., et al. Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. Lung Cancer 66 (2009) 162-168
18. Zochbauer-Muller S., Gazdar A.F., and Minna J.D. Molecular pathogenesis of lung cancer. Annu Rev Physiol 64 (2002) 681-708
19. Cho E.J., Yokozawa T., Rhyu D.Y., Kim H.Y., Shibahara N., and Park J.C. The inhibitory effects of 12 medicinal plants and their component compounds on lipid peroxidation. Am J Chin Med 31 (2003) 907-917
20. Gali H.U., Perchellet E.M., Klish D.S., Johnson J.M., and Perchellet J.P. Antitumor-promoting activities of hydrolyzable tannins in mouse skin. Carcinogenesis 13 (1992) 715-718
21. Inoue M., Sakaguchi N., Isuzugawa K., Tani H., and Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull 23 (2000) 1153-1157
22. Bailey A.E., Asplund R.O., and Ali M.S. Isolation of methyl gallate as the antitumor principle of Acer saccharinum. J Nat Prod 49 (1986) 1149-1150
23. Zhang H., Wang X., Chen F., Androulakis X.M., and Wargovich M.J. Anticancer activity of limonoid from Khaya senegalensis. Phytother Res 21 (2007) 731-734
24. Valcic S., Timmermann B.N., Alberts D.S., et al. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 7 (1996) 461-468
25. Buolamwini J.K. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm Des 6 (2000) 379-392
26. Diehl J.A. Cycling to cancer with cyclin D1. Cancer Biol Ther 1 (2002) 226-231
27. Zhang Y.J., Jiang W., Chen C.J., et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196 (1993) 1010-1016
28. Tashiro E., Tsuchiya A., and Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 98 (2007) 629-635
29. K Ayed A., and Adesina A. Prognostic significance of cyclin D1 expression in resected stage I, II non-small cell lung cancer in Arabs. Interact Cardiovasc Thorac Surg 5 (2006) 47-51
30. Tsuruo T., Nait M., Tomida A., Fujita N., Mashima T., Sakamoto H., et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 94 (2003) 15-21
31. Otsuki Y., Li Z., and Shibata M.A. Apoptotic detection methods - from morphology to gene. Prog Histochem Cytochem 38 (2003) 275-339
32. Boulares A.H., Yakovlev A.G., Ivanova V., et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274 (1999) 22932-22940
33. D'Amours D., Sallmann F.R., Dixit V.M., and Poirier G.G. Gain-of function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114 (2001) 3771-3778